Gillian Morgan

1.1k total citations
31 papers, 916 citations indexed

About

Gillian Morgan is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Gillian Morgan has authored 31 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Hematology. Recurrent topics in Gillian Morgan's work include Multiple Myeloma Research and Treatments (7 papers), Immunotherapy and Immune Responses (5 papers) and Microbial infections and disease research (5 papers). Gillian Morgan is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Immunotherapy and Immune Responses (5 papers) and Microbial infections and disease research (5 papers). Gillian Morgan collaborates with scholars based in Australia, United States and United Kingdom. Gillian Morgan's co-authors include Ian F. C. McKenzie, Roger W. Melvold, David Walliker, Jana S. McBride, Mauro S. Sandrin, Henry I. Kohn, H.I. Kohn, Roger Hall, Andrew Tait and J. Werner Zolg and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Gillian Morgan

31 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Morgan Australia 14 442 239 210 204 199 31 916
Karen Yamaga United States 17 508 1.1× 491 2.1× 273 1.3× 161 0.8× 91 0.5× 39 1.1k
Christopher J. McCormick United Kingdom 20 268 0.6× 295 1.2× 281 1.3× 93 0.5× 425 2.1× 41 1.3k
M. Loche Switzerland 10 300 0.7× 229 1.0× 156 0.7× 47 0.2× 103 0.5× 12 716
J A Mollick United States 16 846 1.9× 241 1.0× 260 1.2× 205 1.0× 114 0.6× 24 1.4k
J.-C. Cerottini Switzerland 12 881 2.0× 240 1.0× 244 1.2× 125 0.6× 175 0.9× 20 1.1k
Jean‐Pierre Rosat United States 11 876 2.0× 154 0.6× 156 0.7× 44 0.2× 335 1.7× 12 1.2k
Jenna J. Guthmiller United States 16 633 1.4× 212 0.9× 216 1.0× 113 0.6× 249 1.3× 32 963
P Potocnjak United States 8 447 1.0× 651 2.7× 400 1.9× 216 1.1× 168 0.8× 8 1.1k
Géraldine Grouard-Vogel France 12 419 0.9× 569 2.4× 114 0.5× 118 0.6× 82 0.4× 16 1.1k
Simona Zompì United States 17 470 1.1× 471 2.0× 233 1.1× 89 0.4× 184 0.9× 28 1.3k

Countries citing papers authored by Gillian Morgan

Since Specialization
Citations

This map shows the geographic impact of Gillian Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Morgan more than expected).

Fields of papers citing papers by Gillian Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Morgan. The network helps show where Gillian Morgan may publish in the future.

Co-authorship network of co-authors of Gillian Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Morgan. A scholar is included among the top collaborators of Gillian Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Morgan. Gillian Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osman, Keren, Ajai Chari, Samir Parekh, et al.. (2016). Phase 1 Study of Elotuzumab in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma. Blood. 128(22). 3448–3448. 1 indexed citations
2.
Chari, Ajai, Hearn Jay Cho, Samir Parekh, et al.. (2015). A phase II study of panobinostat with lenalidomide and weekly dexamethasone in myeloma.. Journal of Clinical Oncology. 33(15_suppl). 8528–8528. 7 indexed citations
3.
Chari, Ajai, Sundar Jagannath, Hearn Jay Cho, et al.. (2015). Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab. Blood. 126(23). 3571–3571. 5 indexed citations
4.
Morgan, Gillian, Jesús F. San Miguel, Sujith Dhanasiri, et al.. (2014). Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
5.
Morgan, Gillian, Brian G.M. Durie, Jesús F. San Miguel, et al.. (2011). Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM). Haematologica. 96. 4 indexed citations
6.
Hauser, Philippe M., Jacques Billé, Cornelia Lass‐Flörl, et al.. (2011). Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay. Journal of Clinical Microbiology. 49(5). 1872–1878. 74 indexed citations
7.
Ngu, J L, Erwei Sun, P J Barr, et al.. (1997). Characterization of a recombinant Onchocerca volvulus antigen (Ov33) produced in yeast.. PubMed. 57(5). 626–33. 13 indexed citations
8.
Hall, Roger, J Mcbride, Gillian Morgan, et al.. (1983). Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Molecular and Biochemical Parasitology. 7(3). 247–265. 117 indexed citations
9.
Morgan, Gillian, et al.. (1983). Human T cell clones allospecific for HLA‐DR5 antigen with the OKT8 phenotype. Tissue Antigens. 22(1). 76–81. 8 indexed citations
10.
McBride, Jana S., David Walliker, & Gillian Morgan. (1982). Antigenic Diversity in the Human Malaria Parasite Plasmodium falciparum. Science. 217(4556). 254–257. 140 indexed citations
11.
Sandrin, Mauro S., et al.. (1981). Ir gene function in an I-A subregion mutant B6.C-H-2bm12.. The Journal of Experimental Medicine. 153(2). 464–469. 56 indexed citations
12.
Morgan, Gillian & Ian F. C. McKenzie. (1981). IMPLICATION OF THE H-2L LOCUS IN HYBRID HISTOCOMPATIBILITY (Hh-1). Transplantation. 31(6). 417–422. 10 indexed citations
13.
Langdon, Wallace Y., Geoffrey Shellam, Gillian Morgan, & Ian F. C. McKenzie. (1980). High titres of antibody to murine leukaemia virus in lymphocyte (Ly) alloantisera. Immunogenetics. 10(1-4). 141–150. 9 indexed citations
14.
Morgan, Gillian, et al.. (1980). Studies of twoH-2D b mutants: B6.C-H-2 bm13 and B6.C-H-2 bm14. Immunogenetics. 11-11(1). 341–349. 16 indexed citations
15.
Morgan, Gillian, Ian F. C. McKenzie, & Roger W. Melvold. (1980). The definition of a new IA antigenic specificity using the B6.C-H-2 bm12 I-region mutant strain. Immunogenetics. 11-11(1). 1–6. 12 indexed citations
16.
Morgan, Gillian, Ian F. C. McKenzie, & Roger W. Melvold. (1980). Studies ofH-2K b mutant mice. Immunogenetics. 11-11(1). 43–53. 8 indexed citations
17.
Potter, Terry A., I F McKenzie, Gillian Morgan, & Marianna Cherry. (1980). Murine lymphocyte alloantigens. I. The Ly-6 locus.. The Journal of Immunology. 125(2). 541–545. 17 indexed citations
18.
Potter, Terry A., Gillian Morgan, & I F McKenzie. (1980). Murine lymphocyte alloantigens. II. The Ly-7 locus.. The Journal of Immunology. 125(2). 546–550. 9 indexed citations
19.
McKenzie, Ian F. C., et al.. (1979). B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.. The Journal of Experimental Medicine. 150(6). 1323–1338. 131 indexed citations
20.
Morgan, Gillian, Ian F. C. McKenzie, & Roger W. Melvold. (1978). The relationship between theH-2 loss mutations ofH-2da andH-2db in the mouse. Immunogenetics. 7(1). 247–258. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Yamaga Breakdown of academic impact, for papers by Christopher J. McCormick Breakdown of academic impact, for papers by M. Loche Breakdown of academic impact, for papers by J A Mollick Breakdown of academic impact, for papers by J.-C. Cerottini Breakdown of academic impact, for papers by Jean‐Pierre Rosat Breakdown of academic impact, for papers by Jenna J. Guthmiller Breakdown of academic impact, for papers by P Potocnjak Breakdown of academic impact, for papers by Géraldine Grouard-Vogel Breakdown of academic impact, for papers by Simona Zompì
Rankless by CCL
2026